1 fore day 90) were recorded; serum creatinine (Cr) at day
90 was defined as baseline.
2 Accuracy was defined as the percentage of LDL-CD falling within an est
3 Postpartum
AD was defined as use of antidepressants and/or hospital contact
4 Successful
ageing was defined as good cognitive, motor, and respiratory functio
5 Extravasation of the contrast
agent was defined as anastomotic leakage.
6 Food
allergy was defined as caretaker report of healthcare provider-diagno
7 Allergic rhinitis (
AR)
was defined as one or more positive results on skin prick tes
8 ATWI was defined as T-wave inversion in >/=2 contiguous anterior l
9 Factor
B was defined as a presence of chronic upper airway complicatio
10 BCR was defined as 2 consecutive prostate-specific antigen rises
11 A
case was defined as signs or symptoms of botulism in a prison A in
12 PCR-
CI was defined as molecular diagnostic evidence of influenza vir
13 High
cIMT was defined as a study-specific value >/=90th percentile.
14 Dual-task gait
cost was defined as the percentage change between single- and dual
15 The success
criterion was defined as IOP </= 12 mm Hg without and with antiglaucoma
16 Early
death was defined as death within 1 month of diagnosis.
17 Vitamin B-6
deficiency was defined as PLP <20 nmol/L, and insufficiency as PLP 20-30
18 OCT-based progression
detection was defined as a significant negative trend for either NFL or
19 Moderate
disability was defined as a cognitive score of 70 to 84 and either GMFCS
20 Disagreement was defined as a negative symptom report or no mention of a s
21 A rotor
domain was defined as an area displaying at least 3 consecutive rota
22 A severe critical
event was defined as the occurrence of respiratory, cardiac, allerg
23 An
exacerbation was defined as a burst of systemic corticosteroids lasting 3
24 Exposure was defined as a total TXA dose greater than 10 mg/kg for 50%
25 Technical
failure was defined as no pixel value with a confidence index higher
26 ciated with the marginal status, in which treatment
failure was defined as occurrence of residual or recurrent CIN2+.
27 Mucosal
healing was defined as CD Endoscopic Index of Severity of 0 in CD or
28 High excess PHA (
HEPHA)
was defined as the differences between PHA and chronological
29 HPR was defined as on-clopidogrel P2Y12 platelet reaction units >
30 Mild
hyperoxia was defined as PaO2 between 120 and 200 mm Hg; severe hyperox
31 Unsuccessfully treated
hypertension was defined as daytime ambulatory BP of at least 135/85 mm Hg
32 Neurologic
injury was defined as brain death, seizures, stroke, and intracrania
33 frequency (3, 4, and 6 kHz) were computed, and hearing
loss was defined as a PTA>25 dB in adults and PTA>15 dB in adolesc
34 A Dean scale score of 0 to 2 (</=50% hair
loss)
was defined as treatment success.
35 MR was defined as >/= mild regurgitation on color Doppler in FHS
36 Myopia was defined as a mean spherical equivalent of -0.75 diopters
37 Severe
obesity was defined as a body-mass index (BMI, the weight in kilogram
38 The composite primary
outcome was defined as all-cause mortality or ventricular arrhythmia,
39 Poor visual
outcome was defined as BCVA of worse than 20/40.
40 The primary outcome-opioid
oversupply-
was defined as the number of patients with either filled but
41 A primary cardiac end
point was defined as symptomatic congestive heart failure of New Yo
42 Amyloid-
positivity was defined as 11C-Pittsburgh compound B target-to-cerebellar
43 PD-L1
positivity was defined as expression by immunohistochemistry on >/= 5% o
44 Prevalence was defined as >/=2 IBD-related visits.
45 Molecular
recurrence was defined as loss of MMR (BCR-ABL1:ABL1 ratio >0.1%) on two
46 A
relapse was defined as loss of partial response.
47 Remission was defined as an HRSD17 of 7 following 8 weeks of randomized
48 Treatment
success was defined as a 50% or greater reduction in pain frequency a
49 Off-label
TAVR was defined as TAVR in patients with known bicuspid valve, mo
50 Early fluoroquinolone (FQ)
use was defined as receiving >/=5 doses during the first month of